“…In recent years, the development in diagnostic screening and anticancer treatment has helped breast cancer patients survive/live longer, for whom treatment-related problems can have a Hui-Yan Niu 1 , Chun-Ying Niu 2 , Jia-He Wang 1 , Yi Zhang 1 , Ping He 1 * major impact on their HRQL. Therefore, there has been a lot of interest in conducting HRQL studies among women with breast cancer (Goodwinet al, 2003;Montazeri, 2008;Lemieux et al, 2011).…”